NU
NU, licence 80080154: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- NaturalSci Regulatory Consulting Corp.
- NPN or DIN-HM
- 80080154
- Status
- Active licence
- Licence date
- 20 September 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Sulfate de (4-Aminobutyle)guanidinium Source : Sulfate d'agmatine | 250.0 milligramme | Not calculated |
| Acide hyaluronique Source : Streptococcus equi - capsule extracellulaire bactérienne | 50.0 milligramme | Not calculated |
| Withania somnifera Source : Racine Potency : 5.0 % Withanolides | 125.0 milligramme | Not calculated |
| L-Glutathione Source : Candida utilis - En entier | 200.0 milligramme | Not calculated |
| Acide gamma-aminobutyrique Source : Acide glutamique | 100.0 milligramme | Not calculated |
| Biotine Source : Saccharomyces cerevisiae - en entier | 500.0 microgrammes | Not calculated |
| Acide 1H-pyrrolo(2,3-f)quinoline-2,7,9-tricarboxylique, 4,5-dihydro-4,5-dioxo- Source : Pyrroloquinoline quinone disodium salt | 10.0 milligramme | Not calculated |
| [5R-(5alpha, 9beta, 11E)]-5-amino-11-éthylidène-5 ,6,9,10-tétrahydro-7-méthyl-5 ,9-méthane-cycloocta [b] pyridine-2 (1H)-one Source : Huperzine A | 100.0 microgrammes | Not calculated |
Non-medicinal ingredients
Cellulose, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 1.0 Tous les jours |
Uses authorised in Canada
Traditionally used in Ayurveda to balance aggravated Vata (nervine tonic, sedative). Traditionally used in Ayurveda to balance aggravated Vata (nervine tonic, sedative) and/or used as a sleep aid. Traditionally used in Ayurveda for memory enhancement. Used in Herbal Medicine as an Adaptogen to help increase energy and resistance to stress (e.g. in case of mental and physical fatigue related to stress). Helps to temporarily promote relaxatio. Helps support joint health. A factor in the maintenance of good health. Helps the body to metabolize carbohydrate. Helps the body to metabolize fats. Helps the body to metabolize proteins.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80080154
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.